Evidence map›Paper›PMID 29596472›Full record

ArticlePloS one2018

Evaluation of nationwide supplementary immunization in Lao People's Democratic Republic: Population-based seroprevalence survey of anti-measles and anti-rubella IgG in children and adults, mathematical modelling and a stability testing of the vaccine.

Masahiko Hachiya, Shinsuke Miyano, Yoshio Mori, Emilia Vynnycky, Phath Keungsaneth, Phengta Vongphrachanh, Anonh Xeuatvongsa, Thongchanh Sisouk, Vilasak Som-Oulay, Bouaphan Khamphaphongphane and 6 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it, 39 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Estimates of the global burden of Congenital Rubella Syndrome, 1996-2019.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2023
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 4 institutions in 3 countries.

Masahiko HachiyaBureau of International Health Cooperation, National Center for Global Health and Medicine, Shinjuku, Tokyo, Japan.ORCID 0000-0002-8720-5097
Shinsuke MiyanoBureau of International Health Cooperation, National Center for Global Health and Medicine, Shinjuku, Tokyo, Japan.
Yoshio MoriDepartment of Virology 3, National Institute of Infectious Diseases, Musashimurayama, Tokyo, Japan.
Emilia VynnyckyModelling and Economics Unit, Public Health England, London, United Kingdom.
Phath KeungsanethDepartment of Hygiene and Health Promotion, Ministry of Health, Vientiane Capital, Lao PDR.
Phengta VongphrachanhNational Center for Laboratory and Epidemiology, Ministry of Health, Vientiane Capital, Lao PDR.
Anonh XeuatvongsaNational Immunization Program, Ministry of Health, Vientiane Capital, Lao PDR.
Thongchanh SisoukNational Center for Laboratory and Epidemiology, Ministry of Health, Vientiane Capital, Lao PDR.
Vilasak Som-OulayNational Center for Laboratory and Epidemiology, Ministry of Health, Vientiane Capital, Lao PDR.
Bouaphan KhamphaphongphaneNational Center for Laboratory and Epidemiology, Ministry of Health, Vientiane Capital, Lao PDR.
Bounthanom SengkeopaseuthNational Center for Laboratory and Epidemiology, Ministry of Health, Vientiane Capital, Lao PDR.
Chansay PathammavongNational Immunization Program, Ministry of Health, Vientiane Capital, Lao PDR.
Kongxay PhounphenghakNational Immunization Program, Ministry of Health, Vientiane Capital, Lao PDR.
Tomomi KitamuraBureau of International Health Cooperation, National Center for Global Health and Medicine, Shinjuku, Tokyo, Japan.
Makoto TakedaDepartment of Virology 3, National Institute of Infectious Diseases, Musashimurayama, Tokyo, Japan.
Katsuhiro KomaseDepartment of Virology 3, National Institute of Infectious Diseases, Musashimurayama, Tokyo, Japan.
National Center for Global Health and Medicine · JPNational Institute of Infectious Diseases · JPMinistry of Health · LAPublic Health England · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMeasles outbreaks have occurred in some countries despite supplementary immunization activities (SIA) using measles-containing vaccine with high vaccination coverage. We conducted a cross-sectional seroprevalence survey to estimate population immunity in Lao People's Democratic Republic where repeated mass immunization has failed to eliminate measles. METHODS AND

findingsIn this nationwide multistage cluster sampling survey conducted in 2014 based on probability proportionate to size sampling, blood samples were collected from 2,135 children and adults living in 52 randomly selected villages. Anti-measles and anti-rubella IgG were measured, and IgG prevalence was calculated. We applied mathematical modelling to estimate the number of cases of congenital rubella syndrome (CRS) in 2013 that were averted by the 2011 SIA. A stability testing was applied to the MR vaccine at 4°C, 25°C, and 35°C to examine stability differences between measles and rubella vaccine components. Measles IgG prevalence was significantly lower in the target age groups (5-21 years) of the 2011 SIA using a combination vaccine for measles and rubella vaccine (MR vaccine) than in young adults (22-39 years) (86.8% [95% CI: 83.0-90.6] vs. 99.0% [98.3-99.8]; p<0.001), whereas rubella IgG prevalence was significantly higher (88.2% [84.5-91.8] vs. 74.6% [70.7-78.5]; p<0.001). In the SIA target age groups, prevalence of measles IgG, but not rubella IgG, increased with age. CRS cases prevented in 2013 ranged from 16 [0-50] to 92 [32-180] if the force of infection had remained unchanged or had been reduced by 75%, respectively. In freeze-dried conditions, the measles vaccine component was more heat sensitive than the rubella component.

conclusionsInconsistent IgG prevalence between measles and rubella in Lao PDR can be partly explained by different stability of the measles and rubella vaccine components under heat exposure. Suboptimal vaccine handling may cause insufficient immunogenicity for measles, which subsequently leads to an outbreak despite high SIA coverage, while direct evidence is lacking. Temperature monitoring of the vaccine should be conducted.

Indexed as

AdolescentChildChild, PreschoolCross-Sectional StudiesFemaleHumansImmunoglobulin GLaosMaleMeaslesMeasles VaccineModels, StatisticalRubellaRubella VaccineSeroepidemiologic StudiesSurveys and QuestionnairesImmunoglobulin GMeasles VaccineRubella Vaccine

Identifiers

PMID29596472
PMCPMC5875789
OpenAlexW2794943314

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.